Status
Conditions
Treatments
About
The primary objective of this study is to monitor the safety profile of Trajenta Duo in Korean patients with type 2 diabetes mellitus (T2DM) in a routine clinical setting.
Full description
Study Design:
Post Marketed Study- Observational study
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Potential subjets must meet all of the following inclusion criteria to enter this trial:
Exclusion criteria
Individuals with any of the following characteristics will not be able to enter this study:
724 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal